EX-10 6 filename6.htm EXECUTION COPY CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE...License and Development Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis AMENDED AND RESTATED LICENSE AND DEVELOPMENT AGREEMENT (this “Agreement”) is entered into effective as of July 11, 2013 (the “Effective Date”) by and between
AMENDED AND RESTATED LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • March 25th, 2015 • Affimed N.V. • Pharmaceutical preparations • New York
Contract Type FiledMarch 25th, 2015 Company Industry JurisdictionORDERED that judgment on priority as to Count 1 (the sole count in the interference: Paper 1, pages 6-7) is awarded against Junior Party Kontermann.
AMENDED AND RESTATED LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • June 27th, 2014 • Affimed Therapeutics B.V. • Pharmaceutical preparations • New York
Contract Type FiledJune 27th, 2014 Company Industry JurisdictionORDERED that judgment on priority as to Count 1 (the sole count in the interference: Paper 1, pages 6-7) is awarded against Junior Party Kontermann.